Literature DB >> 24356239

NOD2 deficiency protects against cardiac remodeling after myocardial infarction in mice.

Xiang Li1, Fengli Li, Yongli Chu, Xiaojie Wang, Hongyu Zhang, Yanyan Hu, Yan Zhang, Ziying Wang, Xinbing Wei, Wencheng Jian, Xiumei Zhang, Fan Yi.   

Abstract

BACKGROUND/AIMS: Although the pathogenesis of myocardial infarction (MI) is multifactorial, activation of innate immune system to induce inflammation has emerged as a key pathophysiological process in MI. NOD2, one member of the NOD-like receptor (NLR) family, plays an important role in the innate immune response. This study was to examine the role of NOD2 during MI.
METHODS: MI was induced by permanent ligation of the left coronary artery in wild type and NOD2(-/-) mice and cardiac fibroblasts were isolated.
RESULTS: NOD2 expression was significantly increased in myocardium in post-MI mice. NOD2 deficiency improved cardiac dysfunction and remodeling after MI as evidenced by echocardiographic analysis, reduced the levels of cytokines, inflammatory cell infiltration and matrix metalloproteinase-9 (MMP-9) activity. In vitro, we further found that NOD2 activation induced the activation of MAPK signaling pathways, production of proinflammatory mediators and MMP-9 activity in cardiac fibroblasts.
CONCLUSIONS: Our studies demonstrate that NOD2 is a critical component of a signal transduction pathway that links cardiac injury by exacerbation of inflammation and MMP-9 activity. Pharmacological targeting of NOD2-mediated signaling pathways may provide a novel approach to treatment of cardiovascular diseases.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24356239     DOI: 10.1159/000356618

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  8 in total

1.  TIPE2 acts as a negative regulator linking NOD2 and inflammatory responses in myocardial ischemia/reperfusion injury.

Authors:  Hongyu Zhang; Tianfeng Zhu; Wenwen Liu; Xin Qu; Ye Chen; Ping Ren; Ziying Wang; Xinbing Wei; Yan Zhang; Fan Yi
Journal:  J Mol Med (Berl)       Date:  2015-04-17       Impact factor: 4.599

Review 2.  The NLRP3 inflammasome in acute myocardial infarction.

Authors:  Stefano Toldo; Antonio Abbate
Journal:  Nat Rev Cardiol       Date:  2017-11-16       Impact factor: 32.419

3.  Genetic factors in treatment-related cardiovascular complications in survivors of childhood acute lymphoblastic leukemia.

Authors:  Kateryna Petrykey; Aziz M Rezgui; Mathilde Le Guern; Patrick Beaulieu; Pascal St-Onge; Simon Drouin; Laurence Bertout; Fan Wang; Jessica L Baedke; Yutaka Yasui; Melissa M Hudson; Marie-Josée Raboisson; Caroline Laverdière; Daniel Sinnett; Gregor U Andelfinger; Maja Krajinovic
Journal:  Pharmacogenomics       Date:  2021-09-10       Impact factor: 2.638

4.  Morroniside alleviates coxsackievirus B3-induced myocardial damage apoptosis via restraining NLRP3 inflammasome activation.

Authors:  Weidong Li; Mao Chen; Lishuai Xu; Zhan Lv; Li Chen; Yiling Li; WenFen He
Journal:  RSC Adv       Date:  2019-01-09       Impact factor: 4.036

5.  Mesenchymal stromal cells inhibit NLRP3 inflammasome activation in a model of Coxsackievirus B3-induced inflammatory cardiomyopathy.

Authors:  Kapka Miteva; Kathleen Pappritz; Marzena Sosnowski; Muhammad El-Shafeey; Irene Müller; Fengquan Dong; Konstantinos Savvatis; Jochen Ringe; Carsten Tschöpe; Sophie Van Linthout
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

6.  Caspase recruitment domain-containing protein 9 (CARD9) knockout reduces regional ischemia/reperfusion injury through an attenuated inflammatory response.

Authors:  Xing Qin; Matthew R Peterson; Samantha E Haller; Li Cao; D Paul Thomas; Guanglong He
Journal:  PLoS One       Date:  2018-06-25       Impact factor: 3.240

7.  Silencing of NOD2 protects against diabetic cardiomyopathy in a murine diabetes model.

Authors:  Lin Shen; Li Li; Man Li; Weiling Wang; Wenbin Yin; Wei Liu; Yanyan Hu
Journal:  Int J Mol Med       Date:  2018-09-14       Impact factor: 4.101

Review 8.  Targeting myocardial ischaemic injury in the absence of reperfusion.

Authors:  M V Basalay; D M Yellon; S M Davidson
Journal:  Basic Res Cardiol       Date:  2020-10-14       Impact factor: 17.165

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.